Dr. Connie Tettenborn began her research career studying signal transduction pathways involved in tumor promotion and growth. After academic postdoctoral positions researching angiogenic and hematopoietic growth factors in cell-based systems, she transitioned to industry. She then broadened her experience to include immunodiagnostics, bioconjugation to nanoparticles, and the validation of prototype instrumentation. Working at both established and start-up biotechnology companies, Dr. Tettenborn contributed to projects related to nanotechnology and microfluidic devices. While consulting in a start-up environment, she found that she could contribute significantly to SBIR grants by providing English language editing and then began working as a contract editor. She has edited more than 940 scientific manuscripts covering a broad range of fields, including medicine (e.g., oncology, neurobiology, immunology, and cardiology), chemistry, biochemistry, molecular biology, cell biology, and engineering. These editing assignments focused on clearly and concisely presenting complex scientific concepts and procedures for authors who use English as a second language (ESL). In her free time, Dr. Tettenborn enjoys hiking, backpacking, caving, writing poetry, and painting.
Education: B.A. in Chemistry from Asbury University; Ph.D. in Oncology from the University of Wisconsin-Madison (McArdle Laboratory for Cancer Research).